Prof Anton Hagenbeek at ASH 2014: Brentuximab vedotin therapy for Hodgkin lymphoma - 101271

Spotlight
Video

Prof Anton Hagenbeek at ASH 2014: Brentuximab vedotin therapy for Hodgkin lymphoma

EMJ has 458 videos Subscribe Here

Loading........
Description: At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof Anton Hagenbeek (Academic Medical Center, Amsterdam, Netherlands) discusses the investigational approaches of brentuximab vedotin, an anti-CD30 antibody conjugated to a cytostatic microtubule-disrupting agent, in the treatment of previously untreated and refractory/relapse patients with Hodgkin lymphoma.
Shared By : EMJ
Posted on : 01/26/15
Added : 4 years ago
Category : Hodgkin Lymphoma